Quality of life and multiple sclerosis: Validation of the French version of the MSQOF self-questionnaire (sep-59);Qualite de vie et sclerose en plaques: Validation de la version francophone d'un auto-questionnaire, le SEP-59

Revue Neurologique

Volumn 156, Issue 3, 2000, Pages 247-263

  Vernay, D ^b   Gerbaud, L ^c   Biolay, S ^c   Coste, J ^a   Debourse, J ^c   Aufauvre, D ^c   Beneton, C ^c   Colamarino, R ^c   Glanddier, P Y ^c   Dordain, G ^c   Clavelou, P ^c  

^a Hôpital Cochin ^*  (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIPLE SCLEROSIS; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; ADOLESCENT; ADULT; COGNITIVE DEFECT; DEPRESSION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PSYCHOSEXUAL DISORDER; SOCIAL SUPPORT;

ADOLESCENT; ADULT; COGNITION DISORDERS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SOCIAL SUPPORT;

EID: 0034105279     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. AARONSON NK, ACQUADRO C, ALONSO J, APOLONE G, BUCQUET D, BULLINGER M, BUNGAY K, FUKUHARA S, GANDEK B, KELLER S, et al. (1992). International Quality of Life Assessment (IQOLA) Project. Qual Life Res, 1: 349-351.
2. ALVAREZ LA, La ROCCA NG, SCHEINBERG LC. (1988). Clinical characteristics of fatigue in multiple sclerosis. Arch Neurol, 45: 435-437.
3. ANDREWS FM, WITHEY SB. (1976). Social indicators of well-being: Americans' perception of life quality. New-York, Plenum Press.
4. BEATTY WW. (1993). Cognitive and emotional disturbances in multiple sclerosis. Neurol Clin, 11: 189-204.
5. BRAZIER JE, HARPER R, JONES NM, O'CATHAIN A, THOMAS KJ, USHERWOOD T, WESTLAKE L. (1992). Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Brit Med J, 305: 160-164.
6. The Canadian Burden of Ilness Study Group. (1998). Burden of multiple sclerosis. Part I: Cost of illness. Can J Neurol Sci, 25: 23-30.
7. The Canadian Burden of llness Study Group. (1998). Burden of multiple sclerosis. Part II: Quality of life. Can J Neurol Sci, 25: 31-38.
8. CONFAVREUX C, COMPSTON DAS, HOMMES OR, MCDONALD WI, THOMPSON AJ. (1992). EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiat, 55: 671-676.
9. COSTE J, FERMANIAN F, VENOT. (1995-a) A. Methodological and statistical problems in the construction of composite measurement scales: a survey of six medical and epidemiological journals. Stat Med, 14: 331-345.
10. COSTE J, POUCHOT J. (1995-b). Construction et validation des instruments de mesure de qualité de vie. Rev Rhum, 62 (5bis): 7S-11S.
11. EDAN G and the French and British Multiple Sclerosis Mitoxantrone Trial Group. (1995). Demonstration of the efficacy of mitoxantrone using MRI in multiple sclerosis patients with a very active disease; J Neuroimmunol, (suppl 1): 16 (abstract).
12. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. (1994). The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci, 21: 9-14.
13. FITZPATRICK R, FLECHTER A, GORE S, JONES D, SPIEGELHALTRE D, Cox D. (1992). Quality of life measures in health care. I. Applications and issues in assessment. Brit Med J, 305: 1074-1077.
14. FLEISS JL. (1986). The design and analysis of clinical experiments. New-York: J. Wiley & Sons, 8-13.
15. FREEMAN JA, LANGDON DW, HOBART JC, THOMPSON AJ. (1996). Health related quality of life in people with multiple sclerosis undergoing inpatient rehabilitation. J Neuro Rehab, 10: 185-194.
16. GARATT AM, RUTA DA, ADBALLA MI, BUCKINGHAM JK, RUSSELL IT. (1993). The SF 36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? Brit Med J, 306: 1440-1444.
17. GOODKIN DE, COOKFAIR D, WENDE K. (1992). Inter and intra rater scoring agreement using grades 1.0 to 3.5 of Kurtzke Expanded Disability Status Scale (EDSS). Multiple sclerosis collaborative research group. Neurology, 42: 859-863.
18. HADORN D, HAYS RD. (1991). Multitrait-multimethod analysis of health related quality of life preferences. Med Care, 29: 829-840.
19. HAMILTON BB, LAUGHLIN A, FIEDLER RC, GRANGER CV. (1994). Interrater reliability of the 7 levels functional independence measure (MIF). Scand J Rehab Med, 26: 115-119.
20. HEATON RK, Nelson LM et al. (1995). Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol, 53: 103.
21. IFNB Multiple Sclerosis Group. (1995). Interferon β-1b in the treatment of multiple sclerosis. Neurology, 45: 1277-1285.
22. JACOBS L, COOKFAIR DL, RUDICK RA et al. (1996). Intramuscular recombinant β-interferon for disease progression in multiple sclerosis Ann Neurol, 39: 285-294.
23. JAESCHKE R, GUYATT GH. (1990). How to develop and validate a new quality of life instrument. Quality of life assessment in clinical trials, 47-57.
24. JENKINSON C, WRIGHT L, COULTER A. (1994). Criterion validity and reliability of the SF-36 in a population sample, Qual Life Res, 3: 7-12.
25. JOHNSON KP, BROOKS BR, COHEN JA and the Copolymer 1 Multiple Sclerosis Study Group. (1995). Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis. Neurology, 45: 1268-1276.
26. KORNLITH AB. (1986). Employment in individuals with multiple sclerosis, Int J Rehab Research, 45: 155-165.
27. KRUPP LB, La ROCCA NG, MUIR-NAB J, SCHEINBERG AD. (1989). The fatigue severity scale: application to patient with multiple sclerosis. Arch Neurol, 46: 1121-1123.
28. KURTZKE JF. (1983). Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology, 33: 1444-1452.
29. LA ROCCA N, KALB R, SCHEINBERG L, KENDALL P. (1985). Factors associated with unemployment of patients with multiple sclerosis, J Chron Dis, 38: 203-210.
30. LEPLÈGE A, MESBAH M, Marquis. (1995). Analyse préliminaire des propriétés psychométriques de la version française d'un auto-questionnaire international de mesure de qualité de vie : le MOS SF 36. Rev Epidemio Sant Publ, 43 : 371-379.
31. LEHMAN AF, WARD NC, LINN LS. (1982). Chronic mental patients: The quality of life issue. Am J Psychiat, 139: 1271-1276.
32. LYON CAEN O, CLANET M. (1997). La sclérose en plaques. In pathologie-science, formation, John Libbey Eurotext, pp. 89, Paris.
33. LYONS RA, PERRY HM, LITTLEPAGE BN. (1994). Evidence for the validity of the Short-Form 36 Questionnaire (SF-36) in an elderly population. Age Ageing, 23: 182-184.
34. Mc HORNEY CA, WARE JE, RACZEK AE. (1993). The MOS 36-item short-form health survey (SF36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care, 31: 247-263.
35. Mc HORNEY CA, WARE JE, LU JFR, SHERBOURNE CD. (1994). The MOS 36-Item Short Form Health Survey (SF 36): III Tests of data quality, scaling assumptions and reliability across diverse patients groups. Med Care, 32: 40-66.
36. MIDY F, BÉJEAN S. (1997). Propriétés psychométriques des questionnaires de qualité de vie. Une synthèse méthodologique. J Econ Med, 15, N° 1, 35-48.
37. MINDEN SL, ORAV J, REICH P. (1987). Depression in multiple sclerosis. Gen Hosp Psychiatry, 9: 426-34.
38. PATRICK D, DEYO RA. (1989). Generic and disease-specific measures in assessing health status and quality of life. Med Care, 27: S217-S232.
39. PATY DW, LI DKB, The UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. (1993). Interferon β-1b is effective in relapsing-remitting multiple sclerosis, II: MRI analysis results of a multicenter, randomized, double blind, placebo-controlled trial. Neurology, 43: 662-667.
40. PERNERGER TV, LEPLÈGE A, ETTER JF, ROUGEMONT A. (1995). Validation of a French-language version of the MOS 36-item short form health survey in young healthy adults. J Clin Epidemiol, 48: 1051-1060.
41. POSER C, PATY DW, SCHEINBERG L. (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol, 13: 227-231.
42. RAO SM, LEO GJ, BERNARDIN L, UNVERZAGT F. (1991-a). Cognitive dysfunction in multiple sclerosis: 1 - frequency, patterns and prediction. Neurology, 41: 685-691.
43. RAO SM, LEO GJ, ELLINGTON L, NAUERTZ T, BERNARDIN L, UNVERZAGT F. (1991-b). Cognitive dysfunction in multiple sclerosis: II - Impact on employment and social functioning. Neurology, 41: 692-696.
44. SHAPIRO R. (1994). Symptom management in multiple sclerosis. Ann Neurol, 36: s123-s129.
45. SHERBOURNE C. (1992). Social functioning: sexual problems measures. In STEWART AL, Ware JE, (eds.), Measuring functioning and well being: the medical outcomes study approach, pp. 194-204. NC: Duke university press.
46. SPIRA A, BAJOS N et le groupe ACSF. (1992). Les comportements sexuels en France. La documentation française.
47. STENAGER E, STENAGER EN JENSEN K. (1992). Sexual aspects of multiple sclerosis. Semin Neurol, 12: 120-124.
48. STEWART AL, HAYS RD, WARE JE. (1992-a). Health perceptions energy / fatigue, and health distress measures. In Stewart AL, Ware JE, (eds.), Measuring functioning and well being: the medical outcomes study approach, pp. 143-172. NC: NC: Duke university press.
49. STEWART AL, WARE JE, SHERBOURNE C, WELLS KB. (1992-b). Psychological distress / well-being and cognitive functioning measures. In Stewart AL, Ware JE, (eds.), Measuring functioning and well-being: the medical outcomes study approach, pp. 102-142. NC: Duke university press.
50. TACHIBANA N (1994). Sleep problems in multiple sclerosis. Eur Neurol, 34: 320-323.
51. VICKREY BG, HAYS RD, HAROONI R, MYERS LW, ELLISON GW. (1995). A health-related quality of life measure for multiple sclerosis. Qual Life Res, 4: 187-206.
52. WARE JE, BROOK RH, DAVIES-AVERY A et al. (1980) Conceptualization and measurement of health for adults in the health insurance study, Vol I, Model of health and methodology. Santa Monica, California: Rand Corporation.
53. WARE JE, SHERBOURNE CD. (1992). The MOS 36-item short-form health survey (SF36): I. Conceptual framework and item selection. Med Care, 30: 473-83.
54. WHILLOCK FA, SISKINO MM. (1980). Depression as a major symptom in multiple sclerosis. J Neurol Neurosurg Psychiat, 43: 861.